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s u m m a r y
Objective: MicroRNAs act locally and systemically to impact osteoarthritis (OA) pathophysiology, but
comprehensive profiling of the circulating miRNome in early vs late stages of OA has yet to be conducted.
Sequencing has emerged as the preferred method for microRNA profiling since it offers high sensitivity
and specificity. Our objective is to sequence the miRNome in plasma from 91 patients with early
[KellgreneLawrence (KL) grade 0 or 1 (n ¼ 41)] or late [KL grade 3 or 4 (n ¼ 50)] symptomatic radio-
graphic knee OA to identify unique microRNA signatures in each disease state.
Design: MicroRNA libraries were prepared using the QIAseq miRNA Library Kit and sequenced on the
Illumina NextSeq 550.Counts were produced for microRNAs captured in miRBase and for novel micro-
RNAs. Statistical, bioinformatics, and computational biology approaches were used to refine and interpret
the final list of microRNAs.
Results: From 215 differentially expressed microRNAs (FDR < 0.01), 97 microRNAs showed an increase or
decrease in expression in 85% of samples in the early OA group as compared to the median expression
in the late OA group. Increasing this threshold to 95%, seven microRNAs were identified: hsa-miR-335-
3p, hsa-miR-199a-5p, hsa-miR-671-3p, hsa-miR-1260b, hsa-miR-191-3p, hsa-miR-335-5p, and hsa-miR-
543. Four novel microRNAs were present in 50% of early OA samples and had 27 predicted gene targets
in common with the prioritized set of predicted gene targets from the 97 microRNAs, suggesting com-
mon underlying mechanisms.
Abbreviations: OA, Osteoarthritis; KL, KellgreneLawrence; BMI, body mass
index.
* Address correspondence and reprint requests to: M. Kapoor, Arthritis Program,
Krembil Research Institute, University Health Network, 60 Leonard Avenue, Tor-
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Conclusion: Applying sequencing to well-characterized patient cohorts produced unbiased profiling of
the circulating miRNome and identified a unique panel of 11 microRNAs in early radiographic knee OA.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Introduction
The complex pathophysiology of osteoarthritis (OA) results from
an interplay between systemic and local joint factors1. There are
few large-scale studies with clearly defined patient cohorts
profiling molecular differences in circulating factors in OA, partic-
ularly in early stages of disease. Next generation sequencing has
emerged as the gold standard approach for profiling molecular
targets in biospecimens of interest in both health and disease.
Sequencing offers the sensitivity and specificity to detect novel
transcripts and low abundance isoforms that may be unique to
particular disease stages2. Decreases in the cost of sequencing have
made this approach more feasible for analyzing large datasets,
providing the statistical power needed to consider multiple patient
factors alongside molecular factors. As the technology advances,
applications are expanding, and now include sequencing of small
RNAs such as microRNAs.
MicroRNAs are small non-coding ribonucleic acid (RNA) mole-
cules that inhibit expression of their gene targets3. Potentially
important biomarkers for disease, peripheral blood microRNAs are
abundant, relatively stable, and detectable through minimally
invasive means4,5. MicroRNAs play key roles in OA pathophysi-
ology6, having been identified in several human joint tissues and
fluids including knee and hip cartilage7, synovium8, spine carti-
lage9, synovial fluid10 and plasma11. Previous studies have used
real-time PCR11, real-time PCR array12, microarray13e15, and next
generation sequencing16,17 to identify circulating microRNAs in OA
vs control, but the only two studies to use sequencing did not report
significant differences16,17. To the best of our knowledge,
sequencing has never been applied to identify circulating micro-
RNA signatures between early and late symptomatic radiographic
knee OA.
Here we use sequencing to profile circulating microRNAs in
blood plasma from 91 patients with symptomatic radiographic
knee OA18,19. The early radiographic knee OA cohort (n ¼ 41)
included patients with KellgreneLawrence (KL) grades 0 or 1, and
the late radiographic knee OA cohort (n ¼ 50) included patients
with KL grades 3 or 4. Patients with KL grade 2 were excluded in
order to clearly differentiate the early OA group from the late OA
group. We identified a distinct signature of plasma microRNAs in
early OA, consisting of sevenmicroRNAs and four novel microRNAs.
With an integrated computational biology approach, we identified
putative downstream gene targets and pathwaysmodulated by this
microRNA signature in early OA.
Methods
Early and late symptomatic radiographic knee OA cohorts
In this study, we utilized blood plasma samples from three knee
OA cohorts (Fig. 1). Our first cohort, The Arthritis Program Early
Knee OA cohort, at the University Health Network (UHN; Toronto,
Canada), comprised plasma samples (n ¼ 22) obtained from pa-
tients with KL grade 1 and persistent pain for at least 4 weeks.
These patients were diagnosed by orthopaedic surgeon R.G. Our
second cohort, theWestern Ontario Registry for Early Osteoarthritis
(WOREO) Knee Study, at the University of Western Ontario (Lon-
don, Canada), included plasma samples (n ¼ 19) from patients
referred to the St. Joseph's Health Care London Rheumatology
Centre with symptomatic early OA (KL grade 0 or 1) who answered
‘yes’ to having frequent knee symptoms on most days for at least 4
weeks. These patients were diagnosed by rheumatologist T.A. Our
third cohortincluded plasma samples (n ¼ 50) from our Longitu-
dinal Evaluation in the Arthritis Program (LEAP) cohort (UHN;
Toronto, Canada) comprised of patients exhibiting KL grades 3 and
4. All patients were symptomatic and fulfilled the American College
of Rheumatology clinical criteria for knee OA classification18. Blood
samples were collected in K2-EDTA tubes, centrifuged at 4,000 rpm
for 10 min at 4 C, aliquotted into 250 mL per cryovial, flash frozen
with liquid nitrogen, and stored in a cryo freezer until use.
Sequencing of microRNAs
RNAwas extracted from 200 mL of human plasma (n ¼ 99) using
the QIAcube semi-automated system following manufacturer's in-
structions for the miRNeasy Serum/Plasma Advanced Kit (Qiagen,
Hilden, Germany). Low concentrations prevent quality and quantity
checks of RNA eluate (18 mL in nuclease-free water), so volumetric
measures are used. cDNA libraries (n ¼ 50 late OA; n ¼ 49 early OA)
were prepared from 5 mL RNA using the QIAseq miRNA Library Kit
according to manufacturer's recommendations for biofluid sam-
ples. A detailed protocol is provided in Supplementary File 1. A key
advantage of this method is that unique molecular indexes (UMIs)
are incorporated during cDNA synthesis, uniquely tagging each
strand prior to amplification, which more accurately reflects
endogenous microRNA levels by controlling for library amplifica-
tion bias.
Individual libraries were quantified using a fluorometric high
sensitivity dsDNA assay (DeNovix, Wilmington, DE, USA). Library
quality was assessed on a high sensitivity DNA chip on the Bio-
analyzer (Agilent, Santa Clara, CA, USA). On the day of sequencing,
library batches were pooled, re-quantified (DeNovix), denatured
and diluted to 1.5 pM, and spiked with 1% PhiX Sequencing Control
V3 library, which acts as a quality metric for cluster generation,
sequencing, and alignment. Spiked library pools were sequenced
on Illumina's NextSeq 550 system using a high-output kit v2
following a 76-base single-end read protocol (Illumina, San Diego,
CA, USA) at the Arthritis Centre for Diagnostic and Therapeutic
Innovation (Krembil Research Institute, Toronto, ON, Canada). Data
were deposited in the Gene Expression Omnibus database under
accession number GSE151341.
Sequencing data alignment and counts generation
An overview of this method is provided in Supplementary
Figure 3. Demultiplexing of.bcl files and conversion into Fastq files
was performed, followed by flagging quality parameters such as
insufficient number of reads (<400,000 reads), low sequence
quality scores (<Q20), low percentage duplication (20%), and poor
3’ adapter contamination (<40%) in reads. Random UMIs of 12 bp
length were extracted for later deduplication of reads. Regular
expression pattern was used in UMI-tools software to select reads
S.A. Ali et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
YJOCA4694_proof ■ 7 August 2020 ■ 2/12
Please cite this article as: Ali SA et al., Sequencing identifies a distinct signature of circulating microRNAs in early radiographic knee
osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.2020.07.003Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 18, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
containing less than two mismatches in the 3’ adapter sequence
mentioned, followed by a 12 bp random UMI tag sequence, and the
remaining part of the read was discarded. We discarded reads of
less than 18bp as too short and reads greater than 30 bp as too long
given that microRNAs are typically 22e25 bp in length.
Alignment of reads was carried out against mature microRNA
sequences from miRBase v22.1 with the following parameters: no
mismatches in a seed read length of 30 bp, no alignment to for-
ward/reverse-complement reference strand, and reporting only the
best hits found in a strata of reads. Unaligned reads were kept
separate from this step. Deduplication of aligned reads based on
UMIs was performed to correctly assign the number of reads for
each mature microRNA in miRBase v22.1. The second round of
alignment involved using the unaligned reads against the human
reference genome (vGRCh38) with the same parameters except
allowing one mismatch instead of zero. Annotation was performed
only for those regions which aligned between the chromosomal
coordinates of human mature microRNAs from miRBase v22.1
andcounts were generated. Finally, each microRNA from miRBase
v22.1 was assigned a combined total count of mature microRNA
Fig. 1
Overview of experimental workflow. Cohorts of early OA (n ¼ 41) and late OA (n ¼ 50) were subjected to
sequencing of microRNAs isolated from blood plasma. Sequential filtration of microRNAs resulted in the
final lists used for computational analyses to predict gene targets and pathways.
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reads as well as genome based mature microRNA region reads
mapping to 2,656 mature microRNAs.
Statistics
Samples with low numbers of aligned reads were removed from
the analysis based on having log-reads below the 0.025 normal
quantile of the log-reads distribution across all samples (n¼ 8 early
OA samples). MicroRNAs were filtered to have at least 10 counts-
per-million (CPM) of classified sequences in at least two samples.
For principal component analysis, counts were transformed using
variance stabilizing transformation before plotting20. Inference was
performed on the raw counts using a negative binomial regression
estimated by quasi-likelihood21 with trended dispersion and
normalized by total aligned sequences. The trimmed mean of m-
values (TMM) method was not applied as a large number of the
microRNAs were differentially expressed between the early OA
group vs the late OA group, violating the TMM assumptions22.
Covariates potentially affecting differential expression between
microRNAs were screened using univariate models23. A final list of
differentially expressed microRNAs between early OA and late OA
samples was obtained using a multivariate model adjusted for age,
sex, BMI, race, collection site, and batch, and filtered using a false
discovery rate (FDR) of 0.01, estimated by the Benjamini-Hochberg
(BH) method. The analysis was implemented in R 3.6.1 using the
edgeR package (v3.28.0).
Novel microRNA analysis
Discovery of novel microRNAs was performed using miRDeep
v224. This did not include processing of UMI tags, instead duplicate
reads were removed based on the read alone. Reads were aligned to
the human reference genome (vGRCh38) and used by miRDeep2.pl
script, where novel microRNAs were discovered by providing hu-
man mature and hairpin microRNA sequences along with mouse
mature microRNA sequences for homology assessment. Using
custom scripts, only those mature microRNAs were selected which
had a significant randfold score and no homology with mouse
mature microRNAs.
Gene target and pathway enrichment analysis
MicroRNA gene targets were predicted using mirDIP 4.125, and
the top 1% of targets for eachmicroRNAwere used. Novel microRNA
gene targets were predicted using BiTargeting26, miRanda v3.3a27,
and miRAW28 using the default parameters specific to each tool,
and the top 1% of targets from each prediction tool was used. Po-
tential human 3’UTR targets were downloaded from the AURA
v2.4.4 database website29. Targets from both predictions were used
to calculate pathway enrichment, using pathDIP 4.0.21.230 and
“Literature curated” pathways excluding Kyoto Encyclopedia of
Genes and Genomes (KEGG) due to its lack of specificity to OA31.
Only pathways with q-value (FDR: BH-method) <0.05 were
retained. Protein-protein interactions (PPIs) among targets were
obtained from IID version 2018-1132. A network was built using
NAViGaTOR 3.0.8, including microRNA to target interactions and
PPIs. Genes and microRNAs from the network were used to query
the Arthritis Data Integration Portal (ADIP; http://ophid.utoronto.
ca/adip/), and if present in the database, were highlighted in the
network according to the type of study in which they were
identified.
Study approval
Written informed consent was obtained from all participants
prior to inclusion in the study. All studies were performed under
research ethics board (REB) approval from the UHN (REB # 16-5969
and REB # 14-7592) and the University of Western Ontario (REB #
109255).
Covariate Total (n ¼ 91) KL0/1 (n ¼ 41) KL3/4 (n ¼ 50) p-value
SEX 0.55
Female 49 (54) 24 (59) 25 (50)
Male 42 (46) 17 (41) 25 (50)
AGE 0.001
Mean (SD) 59.5 (13.6) 50.4 (13.6) 66.9 (8.1)
Median (min, max) 61 (24, 85) 52 (24, 76) 67 (51, 85)
BMI 0.35
Mean (sd) 27.7 (4.5) 27.3 (4.9) 28 (4.2)
Median (min,max) 26.7 (19.9, 44.6) 26 (19.9, 44.6) 26.9 (21, 38.4)
BMI Category 0.51
Normal 29 (32) 15 (37) 14 (28)
Overweight 37 (41) 17 (41) 20 (40)
Obese 25 (27) 9 (22) 16 (32)
RACE 0.022
Non-White 20 (22) 14 (34) 6 (12)
White 71 (78) 27 (66) 44 (88)
Table I
Patient characteristics. Frequencies (%) are provided for categorical variables while mean (standard
deviation¼ SD) and median (min, max) are presented for continuous variables in the full cohort (n¼ 91)
and for the early OA vs late OA groups. Non-parametric KruskaleWallis tests are applied for com-
parisons of continuous variables. Chi-square tests are applied for comparisons of categorical variables.
Shown in bold are statistically significant p-values
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Results
Establishing a pipeline for sequencing microRNAs in human OA
plasma
The microRNA-sequencing pipeline we used was carefully
documented to support reproducibility (Fig. 1). A limitation of
existing sequencing studies is the lack of granularity in reporting
sequencingmethods and data analysis used to produce final results.
In addition to describing our cohorts (Table I), we provide detailed
methods for blood sample acquisition, microRNA isolation, library
preparation, quality control assessment, sequencing, read align-
ment, UMI analysis, counts generation, normalization, and statis-
tical and bioinformatics approaches applied. RNA containing
Fig. 2
Clustering analysis of microRNA sequencing data. (A) Principal component analysis plot with points
coloured according to early OA or late OA. (B) Principal component analysis plot with points coloured
according to (LeR) sex, race, age categorical (AGE_CAT), age continuous (AGE_CON), BMI categorical
(BMI_CAT; 18.5e24.9 ¼ normal; 25e29.9 ¼ overweight; 30þ ¼ obese), BMI continuous (BMI_CON).
Osteoarthritis
andCartilage
S.A. Ali et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx 5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
YJOCA4694_proof ■ 7 August 2020 ■ 5/12
Please cite this article as: Ali SA et al., Sequencing identifies a distinct signature of circulating microRNAs in early radiographic knee
osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.2020.07.003Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 18, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
microRNAs was isolated from blood plasma of 99 patients with OA
and subjected to microRNA library preparation (see Supplementary
File 1 for detailed protocol). Fluorometric quantification deter-
mined the mean concentration (±SD) of early OA libraries (n ¼ 49)
was 18.6± 4.4 ng/mL and late OA libraries (n¼ 50) was 19.1 ± 4.0 ng/
mL. Library integrity assessment determined the average library size
of early OA samples was 182 ± 3 bp and late OA samples was
181 ± 2 bp (Supplementary Figure 1).
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Libraries were sequenced and quality assessment of the runs
revealed high quality (mean Q30 of 94.4% ± 1.2 SD) and high yield
(35G ± 3 SD passing filter; Supplementary Figure 2). This resulted in
>13 ± 2 SDmillion raw reads per sample and an average of 2.0 ± 1.2
SD million mapped reads per sample. Eight samples from the early
OA group yielded fewer than 400,000 mapped reads and were
excluded, resulting in n ¼ 41 early OA samples for subsequent
analysis. UMI analysis was performed to account for library
amplification bias (Supplementary Figure 3). Counts generated for
all 2,656 microRNAs from miRBase v22.1 were normalized by total
counts and filtered for microRNAs with at least 10 counts-per-
million (CPM) reads in at least two samples, resulting in 417
microRNAs (Supplementary File 2).
Identifying a panel of circulating microRNAs in early radiographic
knee OA
Early and late OA cohorts were carefully characterized by sex,
age, BMI, and race, where BMI was considered as both a continuous
and categorical variable (Table I). As the first step, overall patterns
in the sequencing data from early and late OA cohorts were visu-
alized in an unbiased manner through dimensionality reduction
and principal component analysis. From this, a distinct cluster of
late OA samples emerged, clearly separating from the early OA
samples [Fig. 2(A)]. Separation to this degree was not observed for
any of the other variables considered, including sex, race, age, and
BMI, whether considered as a categorical or continuous variable
[Fig. 2(B)]. Age and race were identified as significantly different
between groups (Table I), and in the second step were included as
factors in multivariate models used to determine differential
expression of microRNAs in early OA vs late OA. Using a
FDR threshold of less than 0.01, 215 microRNAs were identified.
As the third step, the list of 215 microRNAs was filtered in a
biologically relevant manner, selecting microRNAs expressed
consistently higher or lower across samples in the early OA group as
compared to themedian expression level in the late OA group using
progressing stringency. This filtering yielded 97 microRNAs that
showed higher expression across 85% or more of samples in the
early OA group as compared to the late OA group (Fig. 3(A); Sup-
plementary File 2). Among these, seven microRNAs (hsa-miR-335-
3p, hsa-miR-199a-5p, hsa-miR-671-3p, hsa-miR-1260b, hsa-miR-
191-3p, hsa-miR-335-5p, and hsa-miR-543) had higher expression
in 95% or more of samples in the early OA group, including hsa-
miR-335-3p which was consistently elevated in 100% of early OA
samples, showing a 3.28 log fold difference in early OA vs late OA
[Fig. 3(B)]. When a t-distributed stochastic neighbour embedding
plot was used to visualize the early OA and late OA clusters
generated using these seven microRNAs as variables, clear sepa-
ration of groups was observed [Fig. 3(C)].
Identifying a panel of novel circulating microRNAs in early
radiographic knee OA
Having identified a panel of seven microRNAs in the early OA
cohort, we next investigated whether there were novel microRNAs
present in early OA, as discovery of novel microRNAs is a major
advantage of using sequencing technology. Novel microRNAs were
detected based on their predicted secondary structure and lack of
homology with murine microRNAs (Supplementary Figure 3). Us-
ing progressing stringencies, this list was filtered for novel micro-
RNA sequences that consistently appeared across samples within a
cohort (early OA or late OA). Filtering for novel microRNAs that
were expressed in 85% of samples yielded one novel microRNA in
the early OA cohort (novel_miRNA_11) that was also found in 85%
of samples in the late OA cohort, and four novel microRNAs in the
late OA cohort (novel_miRNA_7, 8, 9, 11) that were also found in
50% of samples in the early OA cohort. The sequence for each
novel microRNA is shown in Fig. 4.
To identify novel microRNAs that were potentially associated
with early OA but not late OA and vice versa, we filtered for novel
microRNAs that were expressed in 50% of samples within a
cohort. This revealed 11 novel microRNAs in the early OA cohort
and nine microRNAs in the late OA cohort, seven of which were
overlapping, leaving four novel microRNAs in the early OA cohort
and two novel microRNAs in the late OA cohort (Fig. 4). The four
novel microRNAs identified in 50% of samples in the early OA
cohort were found in 36% or less of samples in the late OA cohort,
demonstrating that these four novel microRNAs are more
commonly found in patients with early OA than late OA (Fig. 4).
Finally, the novel microRNA sequences were compared to a previ-
ous list of novel microRNAs generated from sequencing 13 different
human tissue types33. As shown in Fig. 4, the sequences for four of
the microRNAs (novel_miRNA_3, 5, 7, 9) were previously reported,
providing independent evidence of the existence of these novel
microRNAs, and supporting the method we used for discovery of
novel microRNAs.
Identifying a panel of circulating microRNAs in late radiographic
knee OA
To identify circulating microRNAs that were associated with late
OA, the list of 215 differentially expressed microRNAs was filtered
for microRNAs which were consistently higher or lower in
expression across samples in the late OA group, as compared to the
median expression level in the early OA group. Filtering for
microRNAs that were expressed in 85% of samples in the late OA
group yielded no microRNAs, but filtering at a minimum threshold
of 50% yielded three microRNAs (Supplementary File 2). The three
microRNAs showed increased expression in late OA as compared to
early OA, with hsa-miR-193b-5p, hsa-miR-193a-5p, and hsa-miR-
455-5p showing higher expression in 62%, 52%, and 50% of late OA
samples, respectively (Supplementary Figure 4). Characterizing
novel microRNAs, novel_miRNA_5 and 6 were identified in 50% of
Fig. 3
Differentially expressed microRNAs in early OA plasma as compared to late OA plasma. (A) Heatmap
showing log fold change in expression of 215 microRNAs with FDR<0.01 in early OA samples (n ¼ 41) as
compared to late OA samples (n ¼ 50). (B) MicroRNAs (n ¼ 7) selected based on higher expression across
95% or more of samples in the early OA group as compared to the median expression in the late OA group.
logFC ¼ log fold change. logCPM ¼ log counts-per-million. FDR ¼ false discovery rate. (C) T-distributed
stochastic neighbour embedding plot, which is a non-linear dimensionality-reduction method, using the
seven microRNAs shown in (B; left graph) as variables to group early OA and late OA samples, as compared
to seven randomly selected microRNAs (right graph).
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late OA samples, with novel_miRNA_5 being previously
described33. Because novel_miRNA_6 was also present in 44% of
samples in the early OA cohort, it is unlikely to be unique to late OA
samples (Fig. 4). Since a larger and more consistently expressed
panel of microRNAs was identified in early OA samples, subsequent
analyses focused on this group.
MicroRNAs, gene targets, and pathway network in early
radiographic knee OA
Having identified a panel of microRNAs in early OA, we next
performed integrated computational analysis to predict down-
stream gene targets and pathways modulated by these microRNAs.
To minimize filtering and maximize discovery of potential in-
teractions, we chose to use the list of 97 microRNAs that were
identified in85% of early OA samples. Gene targetswere predicted
using mirDIP 4.125 and the top 1% of ranked targets for each
microRNA were selected (Supplementary File 3). MicroRNA-gene
pairs that were validated in previous studies according to TarBase
v.7.034 and NPinter v.3.035 were annotated. Using the four novel
microRNAs that were present in 50% of early OA samples, gene
targets were predicted and the top 1% of ranked targets from each
tool were selected (Supplementary File 3). A list of 27 genes was
predicted to be common targets of our four novel microRNAs and of
at least 10 microRNAs from our list of 97 microRNAs in miRbase
(Supplementary File 3). We show that some of these predicted
targets contained the seed sequence for binding by the novel
microRNAs (Supplementary Figure 5).
The 27 genes that were common were subjected to pathway
enrichment analysis using pathDIP 4.0.21.230, and 14 pathways
were identified that met a q-value (FDR: BH-method) cutoff of
<0.05 (Supplementary File 4). To visualize relationships between
the microRNAs, gene targets, and pathways, network analysis was
performed using NAViGaTOR 3.0.11 (Supplementary File 5)36.
MicroRNA hsa-miR-548j-5p and novel_miRNA_1 had the greatest
number of predicted gene targets (Supplementary File 3) and
SMAD2 had the greatest number of interactions, including micro-
RNAs targeting it and protein-protein interactions (Fig. 5). It was
Fig. 4
Novel microRNAs identified in early OA and late OA plasma. Sequences for 13 novel microRNAs that
were expressed in 50% or more of samples within each group (Early OA or Late OA). Frequencies (%) and n
values are provided for each group and each microRNA, with only those in 50% or more of samples shown
in black. Sequences for novel microRNAs were cross-referenced to those reported by Londin et al.33 and
indicated as ‘Present’ if previously reported or ‘Absent’ if not.
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present in six of the 14 significant pathways, including the most
significant pathway ‘Signaling by TGF-beta Receptor Complex’
(p < 0.01; Fig. 5, Supplementary File 4). Results from Arthritis Data
Integration Portal (ADIP) revealed that among our 27 predicted
genes, two were previously identified in the blood of OA patients as
compared to healthy controls37, 13 were previously identified when
comparing early to late stages of OA synovial fluid and synovial
membrane38, and nine were dysregulated in other joint tissues
(Fig. 5).
Discussion
By sequencing circulating microRNAs, we identified a distinct
panel of 11 microRNAs in early symptomatic radiographic knee OA,
which included four novel microRNAs. We used biologically
meaningful prioritization methods to identify 215 microRNAs that
were differentially expressed between early and late OA cohorts, 97
of which were consistently higher in 85% of early OA samples as
compared to late OA samples. Further filtering revealed seven
microRNAs that were able to separate early OA and late OA samples
based on their presence in95% of early OA samples.We also found
13 novel microRNAs that were present in 50% of samples within a
group, nine of which had not been previously described33, and four
of which were associated with early OA. Since there remain
uncharacterized tissue-specific microRNAs33, the novel microRNAs
identified here merit further investigation as OA-specific markers.
Unlike studies that use arrays or sequencing to identify candi-
dates of interest in only a subset of their cohort, a major strength of
our study was the use of sequencing to profile the entire cohort of
91 samples. As described by Kok et al., small sample sizes (<25 per
group) in high-throughput microRNA screens are a common pitfall
for the identification of biomarkers given the limited reproduc-
ibility39. Our first filtering step was to select microRNAs with high
abundance (10CPM in two samples), to increase the likelihood
Fig. 5
Network analysis showing microRNAs and predicted gene targets. MicroRNAs (n ¼ 97) are shown on
the left, novel microRNAs are shown on the right (n ¼ 4), and putative common gene targets are shown with
connecting edges. Pathway membership is shown using node colour as per legend. Genes frequently
deregulated in OA according to ADIP are highlighted with node outline as per legend. MicroRNAs targeting
them are connected by edges and have labels of the same color. Purple outline highlights the novel
microRNA previously described by Londin et al.33. Asterisk (*) denotes microRNAs identified in at least
95% of early OA samples.
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of detection in future studies. We then normalized the results by
total counts rather than using traditional methods such as TMM,
which can mask differences between groups by assuming that the
majority of microRNAs are not differentially expressed22. These
methodological decisions led us to discover a panel of 11 micro-
RNAs with increased likelihood for reproducibility.
To interpret the biological relevance of our panel of microRNAs,
including predicting potential functions of novel microRNAs,
computational biology approaches were leveraged. Integration of
predicted gene targets between the 97 microRNAs and 4 novel
microRNAs in early OA revealed 27 common gene targets and
multiple interactions. Demonstrating relevance to OA pathophysi-
ology, several matrix metalloproteinases (n ¼ 9), aggrecanases
(n ¼ 7), and collagens (n ¼ 16) were predicted as targets of the 97
microRNAs. The four novel microRNAs also showed disease rele-
vance, with MMP13, COL6, and COL27 as predicted targets (Sup-
plementary File 3) which could potentially contribute to cartilage
catabolism and anabolism.
Annotation with ADIP revealed potential connections to the
blood, synovial fluid, and synovial membrane (Fig. 5). RAB22A and
PPM1B were previously identified as significantly upregulated in
blood from OA patients as compared to healthy controls37, and in
our prediction results were targeted by 10 microRNAs each (only
one of which was common, hsa-miR-556-3p) and novel_miRNA_1.
Several microRNAs, genes, and connections were annotated based
on reported differences between early stages and late stages of OA
in synovial fluid and synovial membrane38. Among these was hsa-
miR-27b-3p, which was previously shown to be increased in late-
stage vs early-stage knee OA synovial fluid10. Hsa-miR-548j-5p and
novel_miRNA_1 had the most predicted gene targets, including
SMAD2 as a common target, and ‘Signaling by TGF-beta Receptor
Complex’ as the top pathway. This demonstrates the utility of ADIP
in predicting disease-relevant microRNA interactions, where in this
case, downregulation of TGF-beta signaling at the joint level would
be expected to reduce the regenerative potential of cartilage
through suppression of type II collagen, lubricin, and aggrecan
genes that are required for joint homeostasis40.
The circulating microRNAs we identified may reflect an early
signal that induces a cascade of events that contribute to OA.
Experimental validation of our findings is required to identify the
source and target tissue(s) of the microRNAs, whether it be the
cartilage, synovium, bone, adipose tissue, or others. Among the top
11 microRNAs identified, hsa-miR-335-3p and -5p were highly
expressed in 100% and 95% of early OA samples, respectively. Arms
of miR-335 are expressed in osteoblasts41 and mesenchymal stem
cells42, with a role in promoting chondrogenesis43. The presence of
these microRNAs in the blood plasma suggests that they may act
systemically to impact more than one joint or target tissue. Animal
models, where it is possible to modulate microRNAs genetically or
pharmacologically, are required to investigate the potential impact
of these microRNAs in OA pathophysiology. Elucidating the bio-
logical mechanism of these microRNAs may have therapeutic
relevance since microRNAs can be targeted with antisense oligo-
nucleotides44. Given our well-defined cohort of patients and the
optimized microRNA sequencing methodology that was applied,
our results reflect a distinct panel of circulating microRNAs in early
radiographic knee OA. Future studies should be directed towards
understanding the role and mechanism of action of the identified
microRNAs in OA pathology, and to determine if any of these
microRNAs have potential as biomarkers in OA.
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